BioStent Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $16M

BioStent General Information

Description

Developer of a medical device intended to protect from coronary artery diseases. The company's device helps the restoration of blood flow in patients with bioerodible vascular stent, enabling patients to get faster relief from coronary artery diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2180 Sand Hill Road
  • Menlo Park, CA 94025
  • United States
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
Corporate Office
  • 2180 Sand Hill Road
  • Menlo Park, CA 94025
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioStent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 20-Apr-2004 $16M Completed Startup
1. Early Stage VC Completed Startup
To view BioStent’s complete valuation and funding history, request access »

BioStent Patents

BioStent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003287916-A1 A system and apparatus for removal of unwanted substances in a gas flow Inactive 18-Dec-2002
WO-2004054688-A1 A system and apparatus for removal of unwanted substances in a gas flow Inactive 18-Dec-2002

BioStent Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Delphi Ventures (California) Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
Saints Capital Secondary Buyer Minority
Synecor Corporation Minority
To view BioStent’s complete investors history, request access »

BioStent FAQs

  • When was BioStent founded?

    BioStent was founded in 2002.

  • Where is BioStent headquartered?

    BioStent is headquartered in Menlo Park, CA.

  • What industry is BioStent in?

    BioStent’s primary industry is Surgical Devices.

  • Is BioStent a private or public company?

    BioStent is a Private company.

  • What is the current valuation of BioStent?

    The current valuation of BioStent is .

  • What is BioStent’s current revenue?

    The current revenue for BioStent is .

  • Who are BioStent’s investors?

    Delphi Ventures (California), Frazier Healthcare Partners, Saints Capital, and Synecor have invested in BioStent.

  • When was BioStent acquired?

    BioStent was acquired on 20-Apr-2004.

  • Who acquired BioStent?

    BioStent was acquired by Guidant.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process